Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,224 | 7,217 | 5,341 | 6,923 | 9,361 |
| Other current assets | 20 | 118 | 162 | 143 | 98 |
| TOTAL | $5,529 | $8,637 | $6,125 | $7,368 | $9,779 |
| Non-Current Assets | |||||
| PPE Net | 0 | 114 | 118 | 122 | 127 |
| Intangibles | 8,101 | 8,259 | 8,417 | 8,574 | 8,732 |
| TOTAL | $8,101 | $8,373 | $8,534 | $8,696 | $8,859 |
| Total Assets | $13,631 | $17,009 | $14,659 | $16,065 | $18,637 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,338 | 1,582 | 1,326 | 1,120 | 660 |
| Other current liabilities | 39 | 156 | 269 | N/A | N/A |
| TOTAL | $1,377 | $1,737 | $1,595 | $1,120 | $660 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 47 | 94 | 85 | 162 | 164 |
| TOTAL | $47 | $94 | $85 | $162 | $164 |
| Total Liabilities | $1,424 | $1,831 | $1,680 | $1,282 | $824 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,444 | 7,444 | 7,444 | 2,705 | 1,266 |
| Common Shares | 1 | 1 | 0 | 0 | 0 |
| Retained earnings | -59,900 | -56,862 | -53,146 | -49,583 | -46,405 |
| Other shareholders' equity | 18 | 6 | 0 | -7 | -35 |
| TOTAL | $12,207 | $15,178 | $12,979 | $14,783 | $17,814 |
| Total Liabilities And Equity | $13,631 | $17,009 | $14,659 | $16,065 | $18,638 |